Avita Medical Inc (RCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,611 | -48,587 | -36,966 | -23,779 | -13,859 |
| Depreciation Amortization | 627 | 2,347 | 1,647 | 1,073 | 521 |
| Accounts receivable | -799 | 3,633 | 3,714 | 1,373 | -253 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 901 | N/A |
| Other Working Capital | -2,231 | 3,439 | -596 | -1,548 | 241 |
| Other Operating Activity | 2,942 | 7,973 | 6,444 | 1,442 | 3,041 |
| Operating Cash Flow | $-10,072 | $-31,195 | $-25,757 | $-20,538 | $-10,309 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -1,640 | -1,679 | -745 | -221 |
| Purchase Of Investment | -3,937 | -13,309 | -11,346 | -3,460 | N/A |
| Sale Of Investment | 6,000 | 27,500 | 25,500 | 22,000 | 11,000 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -13 | N/A |
| Other Investing Activity | -3 | -99 | -34 | -13 | -13 |
| Investing Cash Flow | $2,041 | $12,452 | $12,441 | $17,782 | $10,766 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49,081 | N/A | N/A | N/A | N/A |
| Debt Repayment | -42,984 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 15,199 | 15,198 | 374 | 363 |
| Common Stock Repurchased | N/A | 795 | 548 | 548 | N/A |
| Other Financing Activity | 0 | -1,058 | -1,058 | 0 | 0 |
| Financing Cash Flow | $6,097 | $14,936 | $14,688 | $922 | $363 |
| Beginning Cash Position | 10,243 | 14,050 | 14,050 | 14,050 | 14,050 |
| End Cash Position | 8,309 | 10,243 | 15,422 | 12,216 | 14,870 |
| Net Cash Flow | $-1,934 | $-3,807 | $1,372 | $-1,834 | $820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,072 | -31,195 | -25,757 | -20,538 | -10,309 |
| Capital Expenditure | -19 | -1,640 | -1,679 | -745 | -221 |
| Free Cash Flow | -10,091 | -32,835 | -27,436 | -21,283 | -10,530 |